These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

791 related items for PubMed ID: 1551100

  • 21. Activity of tamoxifen and new antiestrogens on estrogen receptor positive and negative breast cancer cells.
    Coradini D, Biffi A, Cappelletti V, Di Fronzo G.
    Anticancer Res; 1994; 14(3A):1059-64. PubMed ID: 8074450
    [Abstract] [Full Text] [Related]

  • 22. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
    Osborne CK, Boldt DH, Estrada P.
    Cancer Res; 1984 Apr; 44(4):1433-9. PubMed ID: 6704960
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME, Katzenellenbogen BS.
    Cancer Res; 1994 Nov 15; 54(22):5867-74. PubMed ID: 7954416
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
    Lau KM, LaSpina M, Long J, Ho SM.
    Cancer Res; 2000 Jun 15; 60(12):3175-82. PubMed ID: 10866308
    [Abstract] [Full Text] [Related]

  • 28. Contrasting ability of antiestrogens to inhibit MCF-7 growth stimulated by estradiol or epidermal growth factor.
    Cormier EM, Jordan VC.
    Eur J Cancer Clin Oncol; 1989 Jan 15; 25(1):57-63. PubMed ID: 2784101
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Expression of insulin-like growth factors and their binding proteins in the estrogen responsive Ishikawa human endometrial cancer cell line.
    Hana V, Murphy LJ.
    Endocrinology; 1994 Dec 15; 135(6):2511-6. PubMed ID: 7527333
    [Abstract] [Full Text] [Related]

  • 31. [In vitro study for hormones and growth factors dependent cell proliferation of endometrial adenocarcinoma cells].
    Hata H, Hamano M, Tsujii A, Togasaki Y, Kuramoto H, Nishida M, Anzai Y, Gurpide E.
    Hum Cell; 1993 Sep 15; 6(3):182-7. PubMed ID: 8297814
    [Abstract] [Full Text] [Related]

  • 32. Disparate effects of triphenylethylene antiestrogens on estrogen and progestin biosyntheses by cultured rat granulosa cells.
    Welsh TH, Jia XC, Jones PB, Zhuang LZ, Hsueh AJ.
    Endocrinology; 1984 Oct 15; 115(4):1275-82. PubMed ID: 6434288
    [Abstract] [Full Text] [Related]

  • 33. Target specificity of selective estrogen receptor modulators within human endometrial cancer cells.
    Bramlett KS, Burris TP.
    J Steroid Biochem Mol Biol; 2003 Jul 15; 86(1):27-34. PubMed ID: 12943742
    [Abstract] [Full Text] [Related]

  • 34. Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations.
    van Agthoven T, van Agthoven TL, Dekker A, Foekens JA, Dorssers LC.
    Mol Endocrinol; 1994 Nov 15; 8(11):1474-83. PubMed ID: 7533260
    [Abstract] [Full Text] [Related]

  • 35. Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen.
    Bentrem D, Dardes R, Liu H, MacGregor-Schafer J, Zapf J, Jordan V.
    Endocrinology; 2001 Feb 15; 142(2):838-46. PubMed ID: 11159857
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens.
    Gottardis MM, Jiang SY, Jeng MH, Jordan VC.
    Cancer Res; 1989 Aug 01; 49(15):4090-3. PubMed ID: 2743303
    [Abstract] [Full Text] [Related]

  • 37. Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens.
    Leblanc K, Sexton E, Parent S, Bélanger G, Déry MC, Boucher V, Asselin E.
    Int J Oncol; 2007 Feb 01; 30(2):477-87. PubMed ID: 17203231
    [Abstract] [Full Text] [Related]

  • 38. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells].
    Nomura Y, Tashiro H, Takaeko F.
    Gan To Kagaku Ryoho; 1985 Apr 01; 12(4):844-50. PubMed ID: 3157351
    [Abstract] [Full Text] [Related]

  • 39. Expression of transforming growth factor alpha antisense mRNA inhibits the estrogen-induced production of TGF alpha and estrogen-induced proliferation of estrogen-responsive human breast cancer cells.
    Kenney NJ, Saeki T, Gottardis M, Kim N, Garcia-Morales P, Martin MB, Normanno N, Ciardiello F, Day A, Cutler ML.
    J Cell Physiol; 1993 Sep 01; 156(3):497-514. PubMed ID: 8360257
    [Abstract] [Full Text] [Related]

  • 40. Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium.
    Jensen J, Kitlen JW, Briand P, Labrie F, Lykkesfeldt AE.
    J Steroid Biochem Mol Biol; 2003 Mar 01; 84(4):469-78. PubMed ID: 12732292
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.